Evotec SE (EVO) Free Cash Flow (2021 - 2026)
Evotec SE's (EVO) quarterly Free Cash Flow came in at $289.17 in Q1 2026, up 102.02% year-on-year from $143.14 in Q1 2025, and up 100.0% quarter-over-quarter from -$95.1 million in Q4 2025.
Evotec SE (EVO) Free Cash Flow (2021 - 2026) Analysis & Trends
Evotec SE has disclosed Free Cash Flow across 6 years of filings, most recently posting $289.17 for Q1 2026.
- Free Cash Flow for Q1 2026 came in at $289.17, up 102.02% year-over-year; the trailing twelve-month figure through Mar 2026 was -$95.1 million (up 10.32% YoY), and the FY2025 annual result was -$95.1 million, up 10.31% from the prior year.
- Free Cash Flow came in at $289.17 for Q1 2026 at Evotec SE, up from -$95.1 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $24.9 million in Q4 2022 to a low of -$190.5 million in Q4 2023.
- The 5-year median for Free Cash Flow is -$8625.7 (2024), against an average of -$21.6 million.
- Peak annual rise in Free Cash Flow reached 255676.65% in 2022, while the deepest fall reached 2943.9% in 2022.
- Evotec SE's Free Cash Flow stood at $24.9 million in 2022, then plunged by 865.92% to -$190.5 million in 2023, then jumped by 44.3% to -$106.1 million in 2024, then climbed by 10.36% to -$95.1 million in 2025, then surged by 100.0% to $289.17 in 2026.
- The last three Free Cash Flow figures came in at $289.17 (Q1 2026), -$95.1 million (Q4 2025), and -$55352.4 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -208.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 291.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 362.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 136.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -38.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -169.83 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 80.53 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 123.09 Mn |
| 10 | Evotec SE | 570.60 Mn | 570.08 Mn | - | 289.17 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 289.17 |
| Mar 31, 2026 | 289.17 |
| Dec 31, 2025 | -95.11 Mn |
| Dec 31, 2025 | -95.11 Mn |
| Sep 30, 2025 | -55,352.42 |
| Sep 30, 2025 | -55,352.42 |
| Jun 30, 2025 | 52,064.49 |
| Jun 30, 2025 | 52,064.49 |
| Mar 31, 2025 | -14,316.15 |
| Mar 31, 2025 | -14,316.15 |
| Dec 31, 2024 | -106.11 Mn |
| Dec 31, 2024 | -106.11 Mn |
| Sep 30, 2024 | 76,188.98 |
| Sep 30, 2024 | 76,188.98 |
| Jun 30, 2024 | -16,334.23 |
| Jun 30, 2024 | -16,334.23 |
| Mar 31, 2024 | -8,625.71 |
| Mar 31, 2024 | -8,625.71 |
| Dec 31, 2023 | -190.49 Mn |
| Dec 31, 2023 | -190.49 Mn |